Skip to main content
Quest Diagnostics

Hemepath Master Class: Myeloid Neoplasms: MPN-MDS-AML

Hemepath Master Class: Myeloid Neoplasms: MPN-MDS-AML

 

This on-demand webinar will discus

  - An overview of myeloid neoplasms (MPN, MDS, and AML)

  - Diagnostic features

  - Molecular signatures

  - A case study

 

This is a recording from a live webinar series in collaboration with The US Oncology Network (USON) that was held in the beginning of 2023.

Date:
Mar 15, 2023

Related content

On-Demand Webinar
Innovations within Precision Oncology Evolution of a Biomarker a Case Study of KRAS-G12C
On-Demand Webinar
Hemepath Master Class: Chronic lymphocytic leukemia CLL small lymphocytic lymphoma SLL
On-Demand Webinar
Unwinding with DDX41 A case presentation regarding DDX41 and its germline predisposition to myeloid neoplasms
On-Demand Webinar
Precision Medicine: Your Role in Advancing the Future of Cancer Care
Test FAQ
Myeloproliferative Neoplasm Diagnosis Molecular Evaluation
Publication
MPN-024 Hypereosinophilic Syndrome: A Catastrophic Pediatric Case

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA certified laboratories that provide HIPAA covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2024 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.